why choose us

Clinical Trials Search

Showing 14,540 of 132,963 result(s)
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

Status: COMPLETED

Condition: Hypercortisolism

Interventions: Mifepristone tablets for once daily oral dosing

Date: 2023-03-06

Skeletal and Dental Changes with Hyrax-type Rapid Maxillary Expander Anchored to Permanent Versus Deciduous Molars

Status: COMPLETED

Condition: Maxillary Hypoplasia

Interventions: The experimental group will have a hyrax rapid maxillary expander anchored on the 2nd deciduous molars (V)

Date: 2023-03-06

Effect of Continuous Versus Cyclic Daytime Enteral Nutrition on Circadian Rhythms in Critical Illness

Status: COMPLETED

Condition: Critical Illness

Interventions: The allocated feeding schedule is followed from the start of enteral nutrition after ICU admission until discharge from the ICU.

Date: 2023-03-06

A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement

Status: COMPLETED

Condition: Arthropathy of Knee

Interventions: The intervention group will receive weekly 1-on-1 health coaching with a very-low calorie nutrition plan prior to total knee replacement and a convent

Date: 2023-03-06

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

Status: COMPLETED

Condition: Polymyalgia Rheumatica

Interventions: Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen

Date: 2023-03-06

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

Status: COMPLETED

Condition: Hormone Disturbance

Interventions: 50 minutes of running on a treadmill

Date: 2023-03-06

Avatrombopag vs. Placebo for CIT in GI Malignancies

Status: NOT_YET_RECRUITING

Condition: Gastrointestinal Cancer

Interventions: Thrombopoietin receptor agonist, tablet taken orally.

Date: 2023-03-06

A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Participants will receive intravenous (IV) tobemstomig for four 21-day cycles

Date: 2023-03-06

Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study

Status: Completed

Condition: Huntington Disease

Interventions:

Cohort 1-Huntington's Disease:

The target blood volume of each phlebotomy visit will be 20 mL.
The minimum accepted volume (in the

Date: 2023-03-06

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

Status: Completed

Condition: Hematopoietic and Lymphoid System Neoplasm

Interventions: Receive family letter and genomic test report

Date: 2023-03-06